Essential genes from c. albicans and a method for screening antimycotic substances using said genes

Details for Australian Patent Application No. 2003204465 (hide)

Owner Aventis Pharma S.A.

Inventors Chalwatzis, Nicolas; Rocher, Corinne; Lalanne, Jean-Louis; Reinhard-Rupp, Jutta; Nitsche, Almut; Margerie, Daniel; Leeuw, Thomas

Agent Callinan

Pub. Number AU-A-2003204465

Parent 60894

Filing date 29 May 2003

Wipo publication date 26 June 2003

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

19 June 2003 Complete Application Filed

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2003204465

27 April 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204466-Method and system for enhancing portrait images

2003204464-A system for preventing the intrusion of a window into a rail vehicle cab in the event of an impact